Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

L-F001 compound

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

AzepinesSulfonamides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
L‐F001, a novel multifunctional ROCK inhibitor, suppresses neuroinflammation in vitro and in vivo: Involvement of NF‐&kgr;B inhibition and Nrf2 pathway activation
Abstract Microglia and astrocytes are largely responsible for inflammatory injury in the brain of Alzheimer's disease (AD… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
2016
2016
L-F001, a Multifunction ROCK Inhibitor Prevents 6-OHDA Induced Cell Death Through Activating Akt/GSK-3beta and Nrf2/HO-1 Signaling Pathway in PC12 Cells and Attenuates MPTP-Induced Dopamine Neuron…
Amounting evidences demonstrated that Rho/Rho-associated kinase (ROCK) might be a novel target for the therapy of Parkinson’s… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2015
2015
L-F001, a multifunctional ROCK inhibitor prevents paraquat-induced cell death through attenuating ER stress and mitochondrial dysfunction in PC12 cells.
Paraquat (PQ) was demonstrated to induce dopaminergic neuron death and is used as a Parkinson's disease (PD) mimetic. Amounting… Expand
2012
2012
A monoclonal antibody against a potential cancer biomarker, human ubiquitin-conjugating enzyme E2.
Human ubiquitin-conjugating enzyme E2, also known as UbcH10, is defined as a cyclin-selective ubiquitin carrier protein and is… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE